A carregar...
Efficacy of concurrent chemoradiotherapy combined with nimotuzumab for low-risk T4 stage nasopharyngeal carcinoma: A pilot study
BACKGROUND: The purpose of this study was to analyze the efficacy and safety of concurrent chemoradiotherapy combined with Nimotuzumab for low-risk T4 stage nasopharyngeal carcinoma (NPC). METHODS: This study included 49 low-risk T4 stage NPC patients treated with concurrent chemoradiotherapy plus N...
Na minha lista:
| Publicado no: | Medicine (Baltimore) |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wolters Kluwer Health
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6160225/ https://ncbi.nlm.nih.gov/pubmed/30235761 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000012503 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|